Breast Cancer Mortality Hot Spots Among Black Women With de Novo Metastatic Breast Cancer

被引:2
|
作者
Han, Yunan [1 ,2 ]
Langston, Marvin [3 ]
Fuzzell, Lindsay [4 ]
Khan, Saira [5 ]
Lewis-Thames, Marquita W. [6 ]
Colditz, Graham A. [1 ,7 ,8 ]
Moore, Justin Xavier [9 ]
机构
[1] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA
[2] China Med Univ, Dept Breast Surg, Hosp 1, Shenyang, Peoples R China
[3] Kaiser Permanente, Northern Calif, Div Res, Oakland, CA USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcomes & Behav, Tampa, FL USA
[5] Univ Delaware, Coll Hlth Sci, Epidemiol Program, Newark, DE USA
[6] Northwestern Univ, Ctr Community Hlth, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA
[7] Barnes Jewish Hosp, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA
[8] Washington Univ, Sch Med, St Louis, MO USA
[9] Augusta Univ, Dept Populat Hlth Sci, Div Epidemiol, Augusta, GA USA
基金
美国国家卫生研究院;
关键词
RACIAL RESIDENTIAL SEGREGATION; AFRICAN-AMERICAN; STAGE IV; INCIDENCE RATES; WHITE WOMEN; DISPARITIES; SURVIVAL; TUMOR; OUTCOMES; IMPACT;
D O I
10.1093/jncics/pkaa086
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Black women living in southern states have the highest breast cancer mortality rate in the United States. The prognosis of de novo metastatic breast cancer is poor. Given these mortality rates, we are the first to link nationally representative data on breast cancer mortality hot spots (counties with high breast cancer mortality rates) with cancer mortality data in the United States and investigate the association of geographic breast cancer mortality hot spots with de novo metastatic breast cancer mortality among Black women. Methods: We identified 7292 Black women diagnosed with de novo metastatic breast cancer in Surveillance, Epidemiology, and End Results (SEER). The county-level characteristics were obtained from 2014 County Health Rankings and linked to SEER. We used Cox proportional hazards models to calculate adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) for mortality between hot spot and non-hot spot counties. Results: Among 7292 patients, 393 (5.4%) resided in breast cancer mortality hot spots. Women residing in hot spots had similar risks of breast cancer-specific mortality (aHR = 0.99, 95% CI = 0.85 to 1.15) and all-cause mortality (aHR = 0.97, 95% CI = 0.84 to 1.11) as women in non-hot spots after adjusting for individual and tumor-level factors and treatments. Additional adjustment for county-level characteristics did not impact mortality. Conclusion: Living in a breast cancer mortality hot spot was not associated with de novo metastatic breast cancer mortality among Black women. Future research should begin to examine variation in both individual and population-level determinants, as well as in molecular and genetic determinants that underlie the aggressive nature of de novo metastatic breast cancer.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Recent trends in breast cancer mortality among white and black US women
    Chevarley, F
    White, E
    AMERICAN JOURNAL OF PUBLIC HEALTH, 1997, 87 (05) : 775 - 781
  • [32] Palliative care utilization and racial and ethnic disparities among women with de novo metastatic breast cancer in the United States
    Giap, Fantine
    Ma, Sung Jun
    Oladeru, Oluwadamilola T.
    Hong, Young-Rock
    Yu, Brian
    Vega, Raymond Mailhot B.
    Brooks, Eric D.
    Singh, Anurag K.
    Okunieff, Paul G.
    Mendenhall, Nancy P.
    Bradley, Julie A.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 200 (03) : 347 - 354
  • [33] Palliative care utilization and racial and ethnic disparities among women with de novo metastatic breast cancer in the United States
    Fantine Giap
    Sung Jun Ma
    Oluwadamilola T. Oladeru
    Young-Rock Hong
    Brian Yu
    Raymond B. Mailhot Vega
    Eric D. Brooks
    Anurag K. Singh
    Paul G. Okunieff
    Nancy P. Mendenhall
    Julie A. Bradley
    Breast Cancer Research and Treatment, 2023, 200 : 347 - 354
  • [34] Survival differences among women with de novo stage IV and relapsed breast cancer
    Dawood, S.
    Broglio, K.
    Ensor, J.
    Hortobagyi, G. N.
    Giordano, S. H.
    ANNALS OF ONCOLOGY, 2010, 21 (11) : 2169 - 2174
  • [35] Twenty-years experience with de novo metastatic breast cancer
    Cortesi, Laura
    Toss, Angela
    Cirilli, Claudia
    Marcheselli, Luigi
    Braghiroli, Barbara
    Sebastiani, Federica
    Federico, Massimo
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (06) : 1417 - 1426
  • [36] De Novo Stage 4 Metastatic Breast Cancer: A Surgical Disease?
    Barbie, Thanh U.
    Golshan, Mehra
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (11) : 3109 - 3111
  • [37] Retrospective Evaluation of Health Disparities in De Novo Metastatic Breast Cancer
    Semmens, Ashlea
    Mzayek, Fawaz
    Lamanilao, Gene
    Curry, Andrea
    Hull, Yoriann
    Berry, Michael
    Fine, Richard
    Gilmore, Richard
    Vidal, Gregory
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 2) : S382 - S383
  • [38] De Novo Stage 4 Metastatic Breast Cancer: A Surgical Disease?
    Thanh U. Barbie
    Mehra Golshan
    Annals of Surgical Oncology, 2018, 25 : 3109 - 3111
  • [39] Axillary lymph node removal in de novo metastatic breast cancer
    Wu, Ya-Lin
    Hong, Yi-Yan
    Zhan, Hong-Liang
    Zhang, Long-Ying
    Wu, San-Gang
    Zhang, Fu-Xing
    GLAND SURGERY, 2024, 13 (07) : 1214 - 1228
  • [40] International Validation of a Staging Model for de novo Metastatic Breast Cancer
    Plichta, Jennifer
    Thomas, Samantha
    Siesling, Sabine
    de Munck, Linda
    Lusque, Amelie
    Grinda, Thomas
    Gondara, Lovedeep
    Chia, Stephen
    Cabrera-Galeana, Paula
    Reynoso-Noveron, Nancy
    Lopez-Tarruella, Sara
    Lopez, Isabel Alvarez
    Edge, Stephen
    Hortobagyi, Gabriel
    CANCER RESEARCH, 2024, 84 (09)